中国四年碱性磷酸酶正确度验证计划评估
该研究总结了中国国家临床检验中心2012至2016年用可交换血清材料开展的碱性磷酸酶正确度验证计划,参与实验室从115家增至287家,精密度通过率均高于85%,但偏倚通过率低于50%,偏倚是标准化的主要障碍。
要点
- ALP精密度通过率四年均高于85%,但偏倚通过率低于50%。
- 封闭系统与开放系统在偏倚通过率上无优劣之分。
- Roche Cobas/Modular呈明显负偏倚,Beckman AU呈正偏倚。
核心结论
- 可交换材料的PT/EQA计划可用于评估ALP对参考程序赋值靶值的正确度。
- ALP偏倚表现突出,是中国ALP标准化的主要障碍。
研究设计与样本
- 研究总结中国国家临床检验中心2012至2016年开展的4年ALP正确度验证计划。
- 制备不同浓度的可交换血清基材料发送至参与实验室。
- 靶值由参考实验室网络赋值。
- 参与实验室数从2012年115家增至2016年287家。
主要发现
- 均相系统与非均相系统的精密度通过率四年均高于85%。
- 偏倚通过率低于50%。
- 均相系统中Roche Cobas/Modular呈明显负偏倚,Beckman AU平均正偏倚突出。
- 非均相系统中四川迈克偏倚通过率57.1%-78.6%,高于Roche Cobas/Modular的4.4%-33.9%和Beckman AU的35.7%-64.8%。
关键数值与推荐
- 以正确度(偏倚)、不精密度(CV)和准确度(总误差)三项指标评估分析性能。
临床怎么用
- 采用可交换材料的能力验证/室间质评计划评估ALP正确度。
- 关注不同检测系统的偏倚特征以改进ALP标准化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Alkaline phosphatase (ALP) is critical for various diseases. The International Federation of Clinical Chemistry and Laboratory Medicine had recommended the new reference procedure in 2011, but many manufacturers did not trace results to the higher procedure. Since 2012, the National Center for Clinical Laboratories (NCCL) in China has organized the trueness verification program (TV) with commutable materials. The present study summarizes the 4-year TV program to give an overview of the measurement standardization for ALP results. Methods Commutable serum-based materials with different concentrations were prepared and sent to participating laboratories. The target values were assigned by the reference lab network. Results The analytical performance was evaluated according to three indexes: trueness (bias), imprecision (CV) and accuracy (total error [TE]). The number of participating laboratories increased from 115 in 2012 to 287 in 2016. The pass rates of precision for homogeneous and heterogeneous systems were all above 85% over the 4 years; however, the pass rates of bias were much lower (<50%). Among the homogeneous systems, Roche Cobas/Modular had an obvious negative bias, whereas the mean positive bias for Beckman AU was prominent. As to the heterogeneous systems, the pass rates of bias for Sichuan Maccura (57.1%-78.6%) were higher than Roche Cobas/Modular (4.4%-33.9%) and Beckman AU (35.7%-64.8%). Conclusions The PT/EQA program with commutable materials can be used to assess the trueness against target values assigned by reference procedures. For ALP, homogeneous systems did not perform better than heterogeneous systems. The bias for ALP performance was notable and was the main obstacle to its standardization in China.
引用
- Wang J, Wang Y, Zhang T, et al. Evaluation of serum alkaline phosphatase measurement through the 4-year trueness verification program in China. Clin Chem Lab Med. 2018. PMID: 30226202. doi:10.1515/cclm-2018-0399
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。